Chloramphenicol: A Review on Pharmacology, Resistance, and Advances in Ocular Drug Delivery Systems
Year: 2026
Type: article
Abstract: Chloramphenicol is one of the earliest broad-spectrum antibiotics introduced into clinical practice and has played a pivotal role in the evolution of antimicrobial chemotherapy. Despite its proven efficacy against a wide range of Gram-positive and Gram-negative bacteria, anaerobes, and intracellular pathogens, its systemic use has been significantly restricted due to serious safety concerns, including dose-dependent reversible bone marrow suppression, rare idiosyncratic aplastic anemia, and gray baby syndrome in neonates. Nevertheless, chloramphenicol continues to be widely used in topical and ophthalmic formulations, particularly in resource-limited settings, owing to its broad antimicrobial coverage, good ocular tissue penetration, and low cost. From a pharmaceutics perspective, chloramphenicol possesses favorable physicochemical properties such as low molecular weight, moderate lipophilicity, and membrane permeability, making it a suitable candidate for localized drug delivery systems. However, poor aqueous solubility, rapid precorneal elimination, low ocular bioavailability, and the emergence of bacterial resistance mechanisms limit the therapeutic effectiveness of conventional ophthalmic formulations. This review provides a comprehensive overview of the chemistry, mechanism of action, pharmacokinetics, antibacterial spectrum, toxicity, resistance mechanisms, and formulation challenges associated with chloramphenicol.Furthermore, recent advances in pharmaceutical technology aimed at improving the ocular delivery of chloramphenicol are critically discussed. These include in-situ gelling systems, polymeric nanoparticles, hydrogels, ocular inserts, lipid-based carriers, and prodrug strategies, all of which seek to enhance ocular residence time, sustain drug release, and minimize systemic exposure and toxicity. In conclusion, advanced drug delivery approaches represent a promising strategy to optimize the safety and efficacy of chloramphenicol for ocular therapy, warranting further preclinical and clinical investigation.
Institution: Rajiv Gandhi University of Health Sciences
Language: English
Subfield: Pharmaceutical Science
Domain: Life Sciences
Open Access status: hybrid
OpenAlex ID: W7204276171
